Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need ...

RDTE offers a high dividend yield with weekly distributions but lacks underlying equities. Read more to see why I'm neutral ...

The market put in some healthy digestion of last week's gap down. Under the hood, there are signs we are rotating into more ...

Live Nation's demand remains robust with strong fan growth, new venue openings, and increased sponsorships. Find out why LYV ...

Morgan Stanley China A Share Fund's net expense ratio is high compared to ETFs but in line with other actively managed funds.

Rising debt and potential energy cost spikes could worsen BASF's financial situation. Read what makes BASFY stock a risky investment now.

Atour Lifestyle Holdings has demonstrated strong growth, with significant revenue increases across its manachised hotels, ...

Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year. See why NVO stock is a Buy.

Service Properties Trust continues to burn cash and faces large debt maturities that will need to be fulfilled by asset sales. See why SVC stock is a Sell.

GE Vernova specializes in electric power industry products and services, achieving double-digit organic revenue and order growth. See why GEV stock is a Buy.

Baidu's weak advertising due to China's soft macro backdrop and early-stage AI development are concerning. Find out why BIDU ...

Lululemon's varying performance in its two largest markets stems from its differing business cycle in each. We believe there ...